Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral Surgery
Efficacy and Tolerability of a Preoperative Oral Nutritional Supplement (preOP Booster) Versus Placebo in Visceral Surgery
1 other identifier
interventional
36
1 country
1
Brief Summary
The purpose of this pilot study is to investigate the effect of an oral nutritional supplement (preOP booster) versus placebo regarding metabolic criteria in patients undergoing elective pancreaticoduodenectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2007
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 16, 2007
CompletedFirst Posted
Study publicly available on registry
July 18, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedDecember 8, 2008
November 1, 2008
10 months
July 16, 2007
December 5, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
laboratory measurements: total endogenous antioxidant capacity, free radicals, CRP;
up to 30 days after surgery
Secondary Outcomes (1)
postoperative complications, pre- and postoperative discomfort (well-being), muscle strength at 7 days post-op, length of stay (hospital / ICU), ambulation time, gastro intestinal tolerance
up to 30 days after surgery
Study Arms (2)
preOP booster
EXPERIMENTALpreOP booster placebo
PLACEBO COMPARATORInterventions
3x1 dosage pre-operatively
Eligibility Criteria
You may qualify if:
- Elective pancreaticoduodenectomy
You may not qualify if:
- Concomitant chemotherapy
- Severe malnutrition (SGA score C)
- Conditions affecting gastric emptying
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fresenius Kabilead
Study Sites (1)
Università Salute-Vita San Raffaele,
Milan, 20132, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marco Braga, Prof MD
Università Salute-Vita San Raffaele, Milan, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
July 16, 2007
First Posted
July 18, 2007
Study Start
July 1, 2007
Primary Completion
May 1, 2008
Study Completion
May 1, 2008
Last Updated
December 8, 2008
Record last verified: 2008-11